Written Question·Department of Health and Social Care·UIN 60649

Prescriptions

Tabled: 17 June 2025

Answered: 3 July 2025

Question

Dr Luke Evans

To ask the Secretary of State for Health and Social Care, whether he has had discussions with the Medicines and Healthcare products Regulatory Agency on reducing overprescribing.

Answer

Karin Smyth

I have discussed with the Medicines and Healthcare products Regulatory Agency (MHRA) concerns raised by Members of Parliament about the adverse effects of antidepressant prescribing, and what the MHRA can do to improve communication on the risks of differ...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 60649) →